tiprankstipranks

New Portfolio - New Portfolio

PerformancePortfolio Details

Richard

New Portfolio
Individual Investor
Ranked #548,880 out of 861,174 TipRanks' Investors
Success Rate
39%
870 out of 2218
profitable transactions
Average Return
3.09%
Average return
per transaction
Share this portfolio:

Portfolio Gain

1-Month Return▲ 1.89%
6-Month Return▲ 22.12%
12-Month Return▲ 64.74%
YTD Return▲ 9.32%
Total Return▲ 60.94%

Best Trade

AssetD-Wave Quantum (QBTS)
Opened at
Closed at
Gain▲ 524.51%

Bio

Performance

16.06%0-16.06%
▲ 10.96%
▲ 2.38%
▲ 4.62%
Oct 2025
▼ 3.68%
▲ 0.19%
▲ 7.20%
Nov 2025
▼ 0.10%
▲ 0.08%
▲ 0.58%
Dec 2025
▲ 4.06%
▲ 1.47%
▲ 5.05%
Jan 2026
▼ 1.33%
▼ 0.86%
▲ 8.39%
Feb 2026
▲ 0.52%
▼ 4.94%
▼ 6.94%
Mar 2026
▲ 16.06%
▲ 10.51%
▲ 0.08%
Apr 2026
▲ 2.08%
▼ 0.09%
▲ 3.08%
May 2026
TipRanks AverageS&P 500Investor Portfolio
▲ 10.96%▲ 2.38%▲ 4.62%
▼ 3.68%▲ 0.19%▲ 7.20%
▼ 0.10%▲ 0.08%▲ 0.58%
▲ 4.06%▲ 1.47%▲ 5.05%
▼ 1.33%▼ 0.86%▲ 8.39%
▲ 0.52%▼ 4.94%▼ 6.94%
▲ 16.06%▲ 10.51%▲ 0.08%
▲ 2.08%▼ 0.09%▲ 3.08%

Recent Activity

Company Name
% of Portfolio
Return
No. of Transactions
Last Transaction
Date
LXEO
Lexeo Therapeutics, Inc.
1.95%
▲ 8.81%
5
Open
May 04, 2026
SSG
Proshares Ultrashort Semiconductors
―
▼ 3.68%
37
Close
May 04, 2026
SDS
ProShares UltraShort S&P500
29.19%
▼ 0.34%
39
Open
May 04, 2026
MLYS
Mineralys Therapeutics, Inc.
1.99%
▼ 14.59%
8
Open
May 01, 2026
OR
OR Royalties
3.64%
▼ 1.48%
1
Open
May 01, 2026
ZBIO
Zenas BioPharma, Inc.
2.9%
▼ 1.55%
21
Buy
Apr 30, 2026
ZNTL
Zentalis Pharmaceuticals
1.35%
▼ 27.82%
5
Open
Apr 30, 2026
GPCR
Structure Therapeutics, Inc. Sponsored ADR
―
▲ 64.35%
9
Close
Apr 30, 2026
ALKEF
Alkane Resources Ltd
2.12%
▲ 17.40%
12
Buy
Apr 30, 2026
RGLD
Royal Gold
9.99%
▲ 4.29%
7
Buy
Apr 29, 2026
NN
NextNav
2.44%
▲ 1.75%
43
Open
Apr 23, 2026
NRIX
Nurix Therapeutics
2.28%
▼ 11.22%
10
Buy
Apr 22, 2026
SPRB
Spruce Biosciences
2.4%
▼ 26.28%
8
Buy
Apr 22, 2026
ARTV
Artiva Biotherapeutics, Inc.
―
▲ 10.45%
27
Close
Apr 22, 2026
SARK
Tradr 1X Short Innovation Daily ETF
―
▲ 1.93%
36
Close
Apr 22, 2026
SABS
SAB Biotherapeutics
1.99%
▼ 11.16%
3
Buy
Apr 22, 2026
DXD
ProShares UltraShort Dow30
―
▼ 0.21%
2
Close
Apr 22, 2026
GHRS
GH Research
2.63%
▲ 6.79%
3
Buy
Apr 22, 2026
QID
ProShares UltraShort QQQ
―
▼ 1.00%
27
Close
Apr 16, 2026
TWM
ProShares UltraShort Russell2000
―
▼ 3.02%
50
Close
Apr 14, 2026